Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

503 Press Releases
DateTitleCompany
18 Nov 10 FDA Advisory Committee Supports Approval of GARDASIL® for Prevention of Anal Cancer and AIN in both Men and Women Merck,
Published by
Business Wire
17 Nov 10 In Phase III Study Merck's Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD Merck,
Published by
Business Wire
11 Nov 10 Merck and Partners Make Progress in Long-Term Commitment to End River Blindness Merck,
Published by
Business Wire
10 Nov 10 Merck Wins TEMODAR® Patent Infringement Lawsuit on Appeal Merck & Co. Inc.,
Published by
Business Wire
30 Oct 10 Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates In Treatment-Failure and Treatment-Naïve Adult Patients with Chronic Hepatitis C Genotype 1 Compared to Control Merck,
Published by
Business Wire
29 Oct 10 Merck Announces Third-Quarter 2010 Financial Results Merck & Co. Inc.,
Published by
Business Wire
22 Oct 10 In Investigational Study, ZOSTAVAX®, Merck's Shingles Vaccine, Reduced Incidence of Shingles in Adults Ages 50 to 59 by Nearly 70 Percent Merck,
Published by
Business Wire
19 Oct 10 New Data on Odanacatib, Merck’s Investigational Cathepsin-K Inhibitor for Osteoporosis, Presented at American Society for Bone and Mineral Research Annual Meeting Merck & Co. Inc.,
Published by
Business Wire
12 Oct 10 Lundbeck and Merck Sign Exclusive Commercialization Agreement for SYCREST® (asenapine) Sublingual Tablets in All Markets Outside of the United States, China and Japan Merck,
Published by
Business Wire
11 Oct 10 Surveys Highlight Advancing Confidence in Erbitux as Only Targeted Treatment to Increase Survival and Potential for Cure in Head and Neck Cancer Merck Serono,
Published by
PharmiWeb.com
11 Oct 10 Surveys Highlight Advancing Confidence in Erbitux as Only Targeted Treatment to Increase Survival and Potential for Cure in Head and Neck Cancer Merck Serono,
Published by
Business Wire
05 Oct 10 Merck to Appeal Reduced Jury Verdict in Federal FOSAMAX® (alendronate sodium) Case Merck & Co. Inc.,
Published by
Business Wire
04 Oct 10 New Data for Erbitux in Prevalent Cancers to Be Revealed at ESMO Merck Serono,
Published by
Business Wire
01 Oct 10 Merck Announces Pivotal Phase III Data for Boceprevir will be Presented at the American Association for the Study of Liver Diseases 2010 Annual Meeting Merck,
Published by
Business Wire
01 Oct 10 Merck to Hold Third-Quarter 2010 Sales and Earnings Conference Call on Oct. 29 Merck & Co. Inc.,
Published by
Business Wire
01 Oct 10 Merck to Appeal Verdict in Massachusetts Medicaid Case Merck & Co. Inc.,
Published by
Business Wire
29 Sep 10 ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor Merck,
Published by
Business Wire
22 Sep 10 Merck Significantly Expands its Patient Assistance Program Offerings to Provide Access to More Medicines for People in Need Merck,
Published by
Business Wire
16 Sep 10 Merck's Non-Profit to Advance Science Education Joins President Obama's Educate to Innovate Campaign Merck,
Published by
Business Wire
02 Sep 10 BRINAVESS™ (vernakalant) for Infusion Approved in the European Union for Rapid Conversion of Recent Onset Atrial Fibrillation Merck and Cardiome Pharma Corp.,
Published by
Business Wire
24 Aug 10 Merck Provides New Funding to Fight HIV/AIDS in Botswana Merck,
Published by
Business Wire
13 Aug 10 Merck Announces Mandatory Conversion of its 6.00% Mandatory Convertible Preferred Stock Merck & Co. Inc.,
Published by
Business Wire
04 Aug 10 In Pivotal Phase III Studies, Merck’s Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained Virologic Response, the Primary Endpoint of the Studies Merck,
Published by
Business Wire
30 Jul 10 Merck Announces Second-Quarter 2010 Financial Results Merck & Co. Inc.,
Published by
Business Wire
28 Jul 10 Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to Hepatitis C Therapy Merck,
Published by
Business Wire
28 Jul 10 Merck Announces Fourth-Quarter 2010 Dividend Merck & Co. Inc.,
Published by
Business Wire
27 Jul 10 Sinopharm and Merck Sign Statement of Mutual Intent Merck,
Published by
Business Wire
27 Jul 10 Sanofi-aventis and Merck Appoint Raul Kohan as CEO for the New Animal Health Joint Venture Merck & Co. Inc.,
Published by
Business Wire
09 Jul 10 Merck Details Plans to Advance Integration of R&D, Manufacturing and Business Operations Worldwide Merck,
Published by
PharmiWeb.com
08 Jul 10 Merck Details Plans to Advance Integration of R&D, Manufacturing and Business Operations Worldwide Merck & Co. Inc.,
Published by
Business Wire
Advertising